{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:45:41Z","timestamp":1776509141346,"version":"3.51.2"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1016\/s1473-3099(01)00092-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T06:45:57Z","timestamp":1027579557000},"page":"156-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":777,"title":["Cationic peptides: effectors in innate immunity and novel antimicrobials"],"prefix":"10.1016","volume":"1","author":[{"given":"Robert EW","family":"Hancock","sequence":"first","affiliation":[]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/S1473-3099(01)00092-5_bib1","doi-asserted-by":"crossref","first-page":"N75","DOI":"10.1097\/00003246-200104001-00004","article-title":"Increasing threat of Gram-negative bacteria","volume":"29","author":"Waterer","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/S1473-3099(01)00092-5_bib2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1517\/13543784.9.8.1723","article-title":"Cationic antimicrobial peptides: towards clinical applications","volume":"9","author":"Hancock","year":"2000","journal-title":"Expert Opin Invest Dis"},{"key":"10.1016\/S1473-3099(01)00092-5_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0952-7915(98)80029-0","article-title":"Antimicrobial peptides of vertebrates","volume":"10","author":"Ganz","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0167-7799(97)01156-6","article-title":"Cationic peptides: a new source of antibiotics","volume":"16","author":"Hancock","year":"1998","journal-title":"Trends Biotechnol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.iy.13.040195.000425","article-title":"Peptide antibiotics and their role in innate immunity","volume":"13","author":"Boman","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-1759(99)00152-0","article-title":"Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system","volume":"232","author":"Gudmundsson","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1016\/S1473-3099(01)00092-5_bib8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences","volume":"8","author":"Hancock","year":"2000","journal-title":"Trends Microbiol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevImmunol.v20.i5.40","article-title":"Cationic antimicrobial peptides and their multifunctional role in the immune system","volume":"20","author":"Scott","year":"2000","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1097-0282(20000405)53:4<281::AID-BIP1>3.0.CO;2-2","article-title":"Synthesis, microbicidal activity, and solution structure of the dodecapeptide from bovine neutrophils","volume":"53","author":"Raj","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/S1473-3099(01)00092-5_bib12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.45.5.1558-1560.2001","article-title":"Synergistic interactions between mammalian antimicrobial defense peptides","volume":"45","author":"Yan","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S1473-3099(01)00092-5_bib13","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1074\/jbc.M008557200","article-title":"Isolation and characterization of human _-defensin-3, a novel human inducible peptide antibiotic","volume":"276","author":"Harder J Bartels","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S1473-3099(01)00092-5_bib14","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/IAI.67.4.2005-2009.1999","article-title":"Biological properties of structurally related _-helical cationic antimicrobial peptides","volume":"67","author":"Scott","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(01)00092-5_bib15","doi-asserted-by":"crossref","first-page":"14504","DOI":"10.1021\/bi0011173","article-title":"Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide and lipid monolayers","volume":"39","author":"Zhang","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/S1473-3099(01)00092-5_bib16","doi-asserted-by":"crossref","first-page":"28978","DOI":"10.1074\/jbc.273.44.28978","article-title":"PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas)","volume":"273","author":"Chan","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/S1473-3099(01)00092-5_bib17","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.41.8.1738","article-title":"Protegrin-1: a broad spectrum, rapidly microbicidal peptide with in vivo activity","volume":"41","author":"Steinberg","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S1473-3099(01)00092-5_bib18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/AAC.43.5.1274","article-title":"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide","volume":"43","author":"Wu","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S1473-3099(01)00092-5_bib19","first-page":"205","article-title":"The genetic basis of microbial resistance to antimicrobial peptides","volume":"78","author":"Groisman","year":"1997","journal-title":"Methods Mol Biol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1126\/science.286.5444.1561","article-title":"Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa","volume":"286","author":"Ernst","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1473-3099(01)00092-5_bib21","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/00221287-146-10-2543","article-title":"Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial peptides and aminoglycosides","volume":"146","author":"MacFarlane","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/S1473-3099(01)00092-5_bib22","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1128\/AAC.44.8.2086-2092.2000","article-title":"Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria","volume":"44","author":"Friedrich","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S1473-3099(01)00092-5_bib23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1074\/jbc.272.2.1171","article-title":"Mutational analysis of a plant defensin from radish (Raphanus sativus L) reveals two adjacent sites important for antifungal activity","volume":"272","author":"De Samblanx","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S1473-3099(01)00092-5_bib24","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1074\/jbc.274.11.7286","article-title":"The cellular target of histatin 5 on Candida albicans is the energized mitochondrion","volume":"274","author":"Helmerhorst","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S1473-3099(01)00092-5_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jac\/44.3.403","article-title":"In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates","volume":"44","author":"Giacometti","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S1473-3099(01)00092-5_bib26","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1096\/fasebj.2.13.3049204","article-title":"In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum","volume":"2","author":"Jaynes","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/S1473-3099(01)00092-5_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/expr.1995.1052","article-title":"Brugia pahangi: the effects of cecropins on microfilariae in vitro and in Aedes aegypti","volume":"80","author":"Chalk","year":"1995","journal-title":"Exp Parasitol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910600225","article-title":"Experimental local therapy of human melanoma with lytic magainin peptides","volume":"60","author":"Soballe","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/S1473-3099(01)00092-5_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1399-3011.1994.tb00569.x","article-title":"Structure-activity analysis of the antitumor and hemolytic properties of the amphiphilic \u03b1-helical peptide, C18G","volume":"44","author":"Peck-Miller","year":"1994","journal-title":"Int J Pept Protein Res"},{"key":"10.1016\/S1473-3099(01)00092-5_bib30","series-title":"Antibiotic resistance and antibiotic development","first-page":"209","article-title":"Peptide antibiotics","author":"Zhang","year":"2000"},{"key":"10.1016\/S1473-3099(01)00092-5_bib31","doi-asserted-by":"crossref","first-page":"15144","DOI":"10.1021\/bi9811617","article-title":"Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa","volume":"37","author":"Matsuzaki","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/S1473-3099(01)00092-5_bib32","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","article-title":"Peptide antibiotics","volume":"43","author":"Hancock","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S1473-3099(01)00092-5_bib33","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1021\/bi000946l","article-title":"Action of antimicrobial peptides: two-state model","volume":"39","author":"Huang","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/S1473-3099(01)00092-5_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-4157(98)00014-8","article-title":"Magainins as paradigm for the mode of action of pore forming polypeptides","volume":"1376","author":"Matsuzaki","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S1473-3099(01)00092-5_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F","article-title":"Mode of action of linear amphipathic alpha-helical antimicrobial peptides","volume":"47","author":"Oren","year":"1998","journal-title":"Biopolymers"},{"key":"10.1016\/S1473-3099(01)00092-5_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0378-1119(93)90168-3","article-title":"Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria","volume":"134","author":"Piers","year":"1993","journal-title":"Gene"},{"key":"10.1016\/S1473-3099(01)00092-5_bib37","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm0000057","article-title":"Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria","volume":"43","author":"Tsubery","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/S1473-3099(01)00092-5_bib38","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1021\/bi9826299","article-title":"Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli","volume":"38","author":"Wu","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/S1473-3099(01)00092-5_bib39","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.150518097","article-title":"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II","volume":"97","author":"Park","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(01)00092-5_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D","article-title":"Animal antimicrobial peptides: an overview","volume":"47","author":"Andreu","year":"1998","journal-title":"Biopolymers"},{"key":"10.1016\/S1473-3099(01)00092-5_bib41","first-page":"17","article-title":"The antimicrobial host defense of Drosophila","volume":"248","author":"Meister","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.286.5437.113","article-title":"Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense","volume":"286","author":"Wilson","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1473-3099(01)00092-5_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood.V97.1.297","article-title":"Inhibition of neutrophil elastate prevents cathelicidin activation and impairs clearance of bacteria from wounds","volume":"97","author":"Cole","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S1473-3099(01)00092-5_bib44","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1128\/IAI.67.11.6084-6089.1999","article-title":"Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide","volume":"67","author":"Bals","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(01)00092-5_bib45","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1128\/IAI.67.7.3267-3275.1999","article-title":"Innate antimicrobial activity of nasal secretions","volume":"67","author":"Cole","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(01)00092-5_bib46","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1073\/pnas.95.25.14961","article-title":"Production of \u03b2-defensins by human airway epithelia","volume":"95","author":"Singh","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(01)00092-5_bib47","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes and T cells","volume":"192","author":"De","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(01)00092-5_bib48","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.4049\/jimmunol.165.6.3358","article-title":"An \u03b1-helical cationic antimicrobial peptide selectively modulates macrophage response to LPS and directly alters macrophage gene expression","volume":"165","author":"Scott","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00675-0","article-title":"The endothelin system in septic and endotoxin shock","volume":"407","author":"Wanecek","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/S1473-3099(01)00092-5_bib50","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.97.16.8856","article-title":"The role of antimicrobial peptides in animal defences","volume":"97","author":"Hancock","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(01)00092-5_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1094\/MPMI.1997.10.4.525","article-title":"A single amino acid substitution in the antimicrobial defense protein cecropin B is associated with diminished degradation by leaf intracellular fluid","volume":"10","author":"Owens","year":"1997","journal-title":"Mol Plant Microbe Interact"},{"key":"10.1016\/S1473-3099(01)00092-5_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-5793(93)81287-A","article-title":"Chemotactic and protease-inhibiting activities of antibiotic peptide precursors","volume":"317","author":"Varbanac","year":"1993","journal-title":"FEBS Lett"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309901000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309901000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:56:43Z","timestamp":1761469003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309901000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S1473309901000925"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(01)00092-5","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic peptides: effectors in innate immunity and novel antimicrobials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(01)00092-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}